[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diagnostics & Diseases Market Research Reports & Industry Analysis

Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).

A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.

This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.

Publications found: 42,431
Sort by:

2013 Analysis of the Cell Surface Markers in the US: Hospitals, Commercial Labs, Ambulatory Care Centers, Physician Offices

US$ 1,800.00

... both technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the ... . This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, including clinical significance and current ...

June 2013 115 pages

2013 Analysis of the Cell Surface Markers in Europe: Hospitals, Commercial Labs, Ambulatory Care Centers

US$ 3,080.00

The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, ... technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the ...

June 2013 125 pages

2013 Analysis of the European Pap Smear/HPV Market

US$ 2,280.00

This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales forecasts by country and market segment. The report examines market ...

June 2013 235 pages

Analysis of the Sexually-Transmitted Disease Testing Market in the US: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis

US$ 3,600.00

This new 278-page report from Venture Planning Group provides analysis of the US sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed ...

June 2013 278 pages

Analysis of the Sexually-Transmitted Disease Testing Market in Europe: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis

US$ 6,320.00

This new 318-page report from Venture Planning Group provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed ...

June 2013 318 pages

Analysis of the Enteric Disease Testing Market in the US: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus,Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

US$ 4,320.00

... suppliers. About this Report This report presents detailed analysis of the Enteric Disease market in the US. Current scientific views on epidemiology and ... presents sales and market share estimates for major suppliers of enteric disease diagnostic products, by tests. Also, the report: Examines market ...

June 2013 314 pages

Analysis of the Enteric Disease Testing Market in Europe: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

US$ 7,520.00

... . About this Report This report presents detailed analysis of the Enteric Disease market in Europe (France, Germany, Italy, Spain, UK). Current scientific ... report presents sales and market share estimates for major suppliers of enteric disease diagnostic products, by test and country. Also, the report: ...

June 2013 363 pages

Analysis of the Respiratory Disease Testing Market in the US: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

US$ 3,680.00

... by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, ...

June 2013 282 pages

Analysis of the Respiratory Disease Testing Market in Europe: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

US$ 6,640.00

... . About this Report This report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, Spain, UK). Current scientific ... presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test and country. Also, the report ...

June 2013 335 pages

2013 Analysis of the US Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

US$ 3,120.00

The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, ...

June 2013 241 pages

2013 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

US$ 5,520.00

The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for HAV NAT, ...

June 2013 295 pages

2013 Analysis of the US HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices—Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT Procedures

US$ 1,840.00

Summary This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments: Hospitals Commercial/Private Laboratories Blood ...

June 2013 250 pages

2013 Analysis of the European HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT Procedures

US$ 3,160.00

Summary This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following ...

June 2013 277 pages

Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)

US$ 1,400.00

... 2018. Diabetes management test and Cancer management test are the leading market in this segment. Renub Research report entitled “Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)” report ...

June 2013 173 pages

2013 Endocrine Function Testing Market in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers

US$ 5,200.00

... variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers” is a unique market and technology assessment ...

June 2013 310 pages

2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs

US$ 1,960.00

... Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will ... , such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs” is a unique ...

June 2013 269 pages

2013 Endocrine Function Testing Market in Germany: Hospitals, Commercial Labs, Physician Offices

US$ 1,960.00

... new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in Germany: Hospitals, Commercial Labs, Physician Offices” is a unique market and technology assessment designed to help current suppliers ...

June 2013 271 pages

2013 Endocrine Function Testing Market in Italy: Hospitals and Commercial Labs

US$ 1,960.00

... Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will ... , such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in Italy : Hospitals and Commercial Labs” is a unique ...

June 2013 269 pages

2013 Endocrine Function Testing Market in Japan: Hospitals and Commercial Labs

US$ 2,200.00

... TPO Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will ... , such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in Japan: Hospitals and Commercial Labs” is a unique ...

June 2013 269 pages

2013 Endocrine Function Testing Market in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers

US$ 1,960.00

... Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will ... as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers ...

June 2013 271 pages

2013 Endocrine Function Testing Market in the UK: Hospitals and Commercial Labs

US$ 1,960.00

... Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will ... , such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in the UK: Hospitals and Commercial Labs” is a unique ...

June 2013 269 pages

2013 Endocrine Function Testing Market in the US: Hospitals, Commercial Labs, Physician Offices

US$ 2,800.00

... new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in the US: Hospitals, Commercial Labs, Physician Offices” is a unique market and technology assessment designed to help current suppliers ...

June 2013 271 pages

2013 Immunoprotein Diagnostic Testing in Europe: Hospital, Commercial Labs, Physician Offices, Ambulatory Care Centers

US$ 5,200.00

... for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Immunoprotein Diagnostic Testing in the Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers” is a unique market and technology ...

June 2013 273 pages

2013 Immunoprotein Diagnostic Testing in France: Hospitals and Commercial Labs

US$ 1,960.00

... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in France: Hospitals and Commercial Labs” is a unique market and technology assessment designed to help current suppliers and potential ...

June 2013 234 pages

2013 Immunoprotein Diagnostic Testing in Germany: Hospitals, Commercial Labs, Physician Offices

US$ 1,960.00

... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in Germany Hospitals, Commercial Labs, Physician Offices” is a unique market and technology assessment designed to help current suppliers and ...

June 2013 236 pages

2013 Immunoprotein Diagnostic Testing in Italy: Hospitals and Commercial Labs

US$ 1,960.00

... variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in Italy: Hospitals and Commercial Labs” is a unique market and technology assessment designed to help current suppliers and potential ...

June 2013 233 pages

2013 Immunoprotein Diagnostic Testing in Japan: Hospitals and Commercial Labs

US$ 2,200.00

... variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in Japan: Hospitals and Commercial Labs” is a unique market and technology assessment designed to help current suppliers and potential ...

June 2013 234 pages

2013 Immunoprotein Diagnostic Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers

US$ 1,960.00

... variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers” is a unique market and technology assessment designed to help current ...

June 2013 236 pages

2013 Immunoprotein Diagnostic Testing in the UK: Hospitals and Commercial Labs

US$ 1,960.00

... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in the UK: Hospitals and Commercial Labs” is a unique market and technology assessment designed to help current suppliers and potential ...

June 2013 234 pages

2013 Immunoprotein Diagnostic Testing in the US: Hospitals, Commercial Labs, Physician Offices

US$ 2,800.00

... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in the US: Hospitals, Commercial Labs, Physician Offices” is a unique market and technology assessment designed to help current suppliers and ...

June 2013 236 pages

US Home/Self-Testing Diagnostic Market: Diabetes, Pregnancy, Ovulation, Occult Blood--Business Challenges and Marketing Strategies for Suppliers

US$ 1,160.00

... Planning Group provides analysis of the major home/self-testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and ... shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of the home/self-testing ...

June 2013 175 pages

Recombinant Coagulation Factors 2013 - The Race to Market and for Market Shares: A Technology & Pipeline Assessment and Corporate Benchmarking Analysis

US$ 2,767.00

... and their competitive position assessed in light of the key success factors. Sources of information are LMP’s proprietary database, scientific literature (abstracts, ... of each major player in the field Downoad Sample Pages: Recombinant Coagulation Factors 2013 – The Race to Market and for Market Shares: A ...

June 2013 129 pages

US Non-Invasive Prenatal Diagnostics - Market Insight

US$ 1,200.00

... pose serious risks of miscarriages and are being replaced by the non-invasive prenatal diagnostics technologies. Although NIPD is a relatively nascent segment of the ... and early diagnosis. Products such as MaterniT21 Plus, Verifi, and Harmony prenatal tests are the current tests available in the market. Around ...

May 2013 60 pages

Physician Views: Recent developments in US diabetes market – impact of safety concerns & emergence of SGLT-2 drug class

US$ 695.00

... of pharmaceutical manufacturers, this week's Physician Views poll will seek feedback from US-based endocrinologists on three key recent developments – discussion regarding pancreatic cancer/pancreatitis ... Physicians View poll will ask US-based endocrinologists: How their prescribing of DPP-4 and GLP-1 products may shift in light of the FDA’s recent assessment ...

May 2013

Breast Cancer Market Report: 2013 Edition

US$ 800.00

... ‘malignant’ (potentially dangerous). ‘Breast cancer’ is a malignant tumor that has developed from cells in the breast. Typically breast cancer either begins in the cells ... over. The present report offers a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions ...

May 2013 55 pages

2013 Analysis of the US Point-of-Care Clinical Chemistry Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 4,400.00

... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major clinical chemistry reagent and ...

May 2013 373 pages

2013 Analysis of the US Point-of-Care Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 4,400.00

... hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major coagulation reagent and instrument ...

May 2013 418 pages

2013 Analysis of the US Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 4,400.00

... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major hematology and flow cytometry ...

May 2013 238 pages

2013 Analysis of the US PT and APTT Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 2,320.00

... hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major reagent and instrument suppliers. ...

May 2013 337 pages

POC Lipid Testing Market in the US: Physician Offices, Emergency Rooms, Ambulatory Care Centers

US$ 2,320.00

... Planning Group contains 22 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, ... for new instruments and reagent systems with potentially significant market appeal during the next five years. Design criteria for ...

May 2013 305 pages

2013 Analysis of the US Point-of-Care Infectious Disease Diagnostics Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers

US$ 4,400.00

... and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test ...

May 2013 795 pages

Competing in the US Point-of-Care Diagnostic Testing Market

US$ 13,200.00

... market segment: Home/Personal Testing Physician Offices/Group Practices Emergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers and by test category: Routine and Special Chemistry Microbiology/Infectious Diseases ...

May 2013 1172 pages

Diagnostic Testing in the US Ancillary Hospital Locations (ER, OR, ICU)

US$ 10,000.00

... among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient. Market Segmentation Analysis ... during the next ten years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry barriers ...

May 2013 973 pages

Diagnostic Testing in the US Physician Offices and Group Practices Supplier Shares and Sales Forecasts for Over 300 Tests

US$ 10,000.00

... for instrument and consumable suppliers. This report will help diagnostic reagent and instrument suppliers develop more effective business, R&D and ... among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. ...

May 2013 970 pages

Emerging US Point-of-Care Testing Market: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 10,000.00

... POC diagnostic technologies and products, by test. Competitive Assessments Assessments of major suppliers and emerging market entrants, including their sales, product ... for new POC instruments and reagent systems with potentially significant market appeal during the next ten years. Design criteria for ...

May 2013 1007 pages

Microbiology in Europe: Market Segment Forecasts and Supplier Shares

US$ 15,760.00

... opportunities and developing effective business strategies. The report provides market segmentation analysis of over 70 diseases and viruses in five countries, assessment of ... the main driving forces behind the growth of this dynamic market is continuous spread of AIDS, which remains the world’s major health ...

May 2013 1600 pages

Nucleic Acid Testing in Europe: Market Segment Forecasts and Supplier Shares

US$ 15,760.00

... next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies ...

May 2013 970 pages

Transfusion Diagnostics in Europe: Market Segment Forecasts and Supplier Shares

US$ 15,760.00

... from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than ...

May 2013 600 pages

Tumor Markers in Europe: Market Segment Forecasts and Supplier Shares

US$ 15,760.00

... and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, ... diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and ...

May 2013 820 pages

Diagnostic Testing in France: Market Segment Forecasts and Supplier Shares

US$ 3,880.00

... Planning Group provides an overview of the French diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers ... volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and ...

May 2013 58 pages

Filters

Search

Categories

675
84
1,065
32,726
152
69
819
657
1,863
4,251
70

Publishers

8
9
35
1
15
4
40
1
1
17
12
4
1
1
13
2
1
53
1
1
9
9
328
1
2
1
5
16
1
1
13
4
40
1
2
8
5
16
19
36
7
10
6
2
3
174
108
13
53
3
29
15
1
4
7
18
3
24
3
32
1
15
2
7
2
81
46
11
77
1
14
2
22
3
74
40,332
1
40
2
17
15
24
85
6
10
50
11
62
48
1
45
23
49

Regions

280
15
1
134
138
137
137
136
136
135
134
131
130
175
38
15,523
447
192
191
191
137
4
3
2
198
197
196
196
196
195
194
194
194
192
106
193
195
193
192
107
195
138
203
194
189
200
198
196
139
105
195
194
194
193
195
176
198
197
138
112
197
197
195
195
193
193
138
138
136
135
135
1
1
200
198
197
195
194
198
197
196
195
195
195
194
194
194
195
195
191
138
138
137
108
16
1
1
198
1
108
1,215
1,213
1,197
1,192
1,172
245
2
263
194
195
203
197
1,227
1,153
1,668

Price

Date

Pages

Offers

33
6
1
15
84